FDA Inspection 1250053 — Alain Gaudric, M.D.
The FDA completed an inspection of Alain Gaudric, M.D. on Sep 13, 2024 in Paris 10e Arrondissement. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 13, 2024
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Paris 10e Arrondissement (France)
Additional details
Clinical Investigator (CI)